HIV Treatment Switching to Disease Prevention
Okay, here’s a breakdown of the key points about HIV treatment as emphasized by Dr. Applin in the provided text, geared towards students and professionals in 2025:
1.Managing Adverse Events (AEs):
* Prioritize Adjustment Before Switching: Small changes to how a medication is taken (with food, timing) can often resolve AEs without needing a full regimen change.
* Modern ARTs are Better tolerated: Treatment changes due to AEs are less frequent now than in the past because newer drugs have fewer side effects.
* Evaluate Resistance: Any regimen change must consider the patient’s resistance history to ensure the new regimen will be effective.
2. drug-Drug Interactions (DDIs):
* Modify Non-HIV Meds First: Whenever possible, adjust other medications the patient is taking before changing the ART regimen. (e.g., switch statins or inhaled steroids).
* Boosted vs. Unboosted: Switching from a boosted to an unboosted regimen can resolve some DDIs.
3. Pregnancy Considerations:
* Growing Safety Data: More evidence supports the safety of many HIV medications during pregnancy.
* Proactive Counseling: Counsel women of childbearing potential about regimens that are both effective now and safe if pregnancy occurs (many pregnancies are unplanned).
* Minimize Disruption: The goal is to maintain stability throughout pregnancy, breastfeeding, and beyond.
* Safety and Resistance Barrier: Prioritize regimens with a strong safety profile and a high barrier to resistance.
4. Maintaining Virologic Suppression & Preserving future Options:
* Know the Resistance History: Essential before any treatment switch. If data is unavailable, review prior regimens.
* Barrier to Resistance is Key: Choose regimens that maintain or increase the barrier to resistance (protease inhibitors have a higher barrier than non-nucleoside reverse transcriptase inhibitors).
* Durability & Long-Term Control: Focus on regimens that will provide durable viral control.
5. Patient-Centered Care:
* Understand Patient Motivation: Actively listen to why a patient wants to switch regimens.
* Shared Decision-Making: Discuss the details of any proposed change (pill burden, clinic visits, coverage) and help the patient clarify their needs.
* Align Preference with Clinical Goals: Support switches that align with clinical needs,resistance history,and adherence.
* Adherence & Satisfaction: Engaging patients in the process improves adherence and overall satisfaction.
Overall Message for 2025:
HIV treatment in 2025 is about optimization, personalization, and proactive planning. it’s not just about getting to undetectable; it’s about maintaining that suppression long-term while minimizing side effects, preserving future treatment options, and respecting patient preferences. The field has advanced to a point where treatment can be highly tailored to individual needs and circumstances.